IL-10 treatment is associated with prohibitin expression in the Crohn's disease intestinal fibrosis mouse model

Mediators of Inflammation

Volumn 2013, Issue , 2013, Pages

  Yuan, C ^a   Chen, W X ^a   Zhu, J S ^a   Chen, N W ^a   Lu, Y M ^a   Ou, Y X ^a   Chen, H Q ^a  

^a SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; PROHIBITIN; TRANSFORMING GROWTH FACTOR BETA1; REPRESSOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; COLON; CONTROLLED STUDY; CROHN DISEASE; DOWN REGULATION; FEMALE; FLUORESCENCE ANALYSIS; GENE SILENCING; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INTESTINAL FIBROSIS; KNOCKOUT MOUSE; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; TISSUE LEVEL; UPREGULATION; WILD TYPE; ANIMAL; COLITIS; DEFICIENCY; DRUG EFFECTS; FIBROSIS; GENETICS; IMMUNOLOGY; INTESTINE; METABOLISM; REAL TIME POLYMERASE CHAIN REACTION; DRUG EFFECT;

ANIMALS; COLITIS; COLON; CROHN DISEASE; FEMALE; FIBROSIS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-10; INTESTINES; MICE; MICE, KNOCKOUT; REAL-TIME POLYMERASE CHAIN REACTION; REPRESSOR PROTEINS;

EID: 84877296582     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/617145     Document Type: Article

References (30)

1. Cosnes J., Crohn's disease phenotype, prognosis, and long-term complications: what to expect? Acta Gastro-Enterologica Belgica 2008 71 303 307
2. Nikolaus S., Schreiber S., Diagnostics of inflammatory bowel disease. Gastroenterology 2007 133 5 1670 1689 2-s2.0-35648958802 10.1053/j.gastro.2007. 09.001 (Pubitemid 350029755)
3. Artal-Sanz M., Tsang W. Y., Willems E. M., Grivell L. A., Lemire B. D., Der Spek H. V., Nijtmans L. G. J., The mitochondrial prohibitin complex is essential for embryonic viability and germline function in Caenorhabditis elegans. Journal of Biological Chemistry 2003 278 41 32091 32099 2-s2.0-0141959257 (Pubitemid 37048398)
4. Rastogi S., Joshi B., Fusaro G., Chellappan S., Camptothecin induces nuclear export of prohibitin preferentially in transformed cells through a CRM-1-dependent mechanism. Journal of Biological Chemistry 2006 281 5 2951 2959 2-s2.0-33646381128 10.1074/jbc.M508669200 (Pubitemid 43845762)
5. Sánchez-Quiles V., Santamaría E., Segura V., Sesma L., Prieto J., Corrales F. J., Prohibitin deficiency blocks proliferation and induces apoptosis in human hepatoma cells: molecular mechanisms and functional implications. Proteomics 2010 10 8 1609 1620 2-s2.0-77951076202 10.1002/pmic.200900757
6. Altus M. S., Wood C. M., Stewart D. A., Roskams A. J. I., Friedman V., Henderson T., Owens G. A., Danner D. B., Jupe E. R., Dell'Orco R. T., McClung J. K., Regions of evolutionary conservation between the rat and human prohibitin-encoding genes. Gene 1995 158 2 291 294 2-s2.0-0028999851 10.1016/0378-1119(95)00164-2
7. Theiss A. L., Idell R. D., Srinivasan S., Klapproth J. M., Jones D. P., Merlin D., Sitaraman S. V., Prohibitin protects against oxidative stress in intestinal epithelial cells. FASEB Journal 2007 21 1 197 206 2-s2.0-33845968031 10.1096/fj.06-6801com (Pubitemid 46052557)
8. Ko K. S., Tomasi M. L., Iglesias-Ara A., French B. A., French S. W., Ramani K., Lozano J. J., Oh P., He L., Stiles B. L., Li T. W., Yang H., Martínez-Chantar M. L., Mato J. M., Lu S. C., Liver-specific deletion of prohibitin 1 results in spontaneous liver injury, fibrosis, and hepatocellular carcinoma in mice. Hepatology 2010 52 6 2096 2108 2-s2.0-78649616487 10.1002/hep.23919
9. Zhou T. B., Qin Y. H., Li Z. Y., Xu H. L., Zhao Y. J., Lei F. Y., All-trans retinoic acid treatment is associated with prohibitin expression in renal interstitial fibrosis rats. International Journal of Molecular Sciences 2012 13 2769 2782
10. Monteleone G., Boirivant M., Pallone F., MacDonald T. T., TGF- β 1 and Smad7 in the regulation of IBD. Mucosal Immunology 2008 1 supplement 1 S50 S53 2-s2.0-54349127897 10.1038/mi.2008.55
11. Verrecchia F., Mauviel A., Farge D., Transforming growth factor- β signaling through the Smad proteins: role in systemic sclerosis. Autoimmunity Reviews 2006 5 8 563 569 2-s2.0-33749338087 10.1016/j.autrev.2006.06.001 (Pubitemid 44488757)
12. Gressner A. M., Weiskirchen R., Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF- β as major players and therapeutic targets. Journal of Cellular and Molecular Medicine 2006 10 1 76 99 2-s2.0-33744538682 10.1111/j.1582-4934.2006.tb00292.x (Pubitemid 44874293)
13. Kalluri R., EMT: when epithelial cells decide to become mesenchymal-like cells. Journal of Clinical Investigation 2009 119 6 1417 1419 2-s2.0-67651005404 10.1172/JCI39675
14. Petit-Bertron A. F., Pedron T., Groß U., Coppée J. Y., Sansonetti P. J., Cavaillon J. M., Adib-Conquy M., Adherence modifies the regulation of gene expression induced by interleukin-10. Cytokine 2005 29 1 1 12 2-s2.0-9644307943 10.1016/j.cyto.2004.09.001 (Pubitemid 39576697)
15. Tamaki H., Nakamura H., Nishio A., Nakase H., Ueno S., Uza N., Kido M., Inoue S., Mikami S., Asada M., Kiriya K., Kitamura H., Ohashi S., Fukui T., Kawasaki K., Matsuura M., Ishii Y., Okazaki K., Yodoi J., Chiba T., Human thioredoxin-1 ameliorates experimental murine colitis in association with suppressed macrophage inhibitory factor production. Gastroenterology 2006 131 4 1110 1121 2-s2.0-33749352225 10.1053/j.gastro.2006.08.023 (Pubitemid 44498706)
16. Song J., EMT or apoptosis: a decision for TGF- β Cell Research 2007 17 4 289 290 2-s2.0-34247359909 10.1038/cr.2007.25 (Pubitemid 46639927)
17. Theiss A. L., Laroui H., Obertone T. S., Chowdhury I., Thompson W. E., Merlin D., Sitaraman S. V., Nanoparticle-based therapeutic delivery of prohibitin to the colonic epithelial cells ameliorates acute murine colitis. Inflammatory Bowel Diseases 2011 17 5 1163 1176 2-s2.0-79953850342 10.1002/ibd.21469
18. Sato T., Saito H., Swensen J., Olifant A., Wood C., Danner D., Sakamoto T., Takita K., Kasumi F., Miki Y., Skolnick M., Nakamura Y., The human prohibitin gene located on chromosome 17q21 is mutated in sporadic breast cancer. Cancer Research 1992 52 6 1643 1646 2-s2.0-0026537861
19. Hsieh S. Y., Shin T. C., Yeh C. Y., Lin C. J., Chou Y. Y., Lee Y. S., Comparative proteomic studies on the pathogenesis of human ulcerative colitis. Proteomics 2006 6 19 5322 5331 2-s2.0-33749638414 10.1002/pmic.200500541 (Pubitemid 44547169)
20. Sato S. I., Murata A., Orihara T., Shirakawa T., Suenaga K., Kigoshi H., Uesugi M., Marine natural product aurilide activates the opa1-mediated apoptosis by binding to prohibitin. Chemistry and Biology 2011 18 1 131 139 2-s2.0-79251577725 10.1016/j.chembiol.2010.10.017
21. Berger K. H., Yaffe M. P., Prohibitin family members interact genetically with mitochondrial inheritance components in Saccharomyces cerevisiae. Molecular and Cellular Biology 1998 18 7 4043 4052 2-s2.0-0031860890 (Pubitemid 28287928)
22. Chen C. L., Chou K. J., Lee P. T., Chen Y. S., Chang T. Y., Hsu C. Y., Huang W. C., Chung H. M., Fang H. C., Erythropoietin suppresses epithelial to mesenchymal transition and intercepts Smad signal transduction through a MEK-dependent mechanism in pig kidney (LLC-PK1) cell lines. Experimental Cell Research 2010 316 7 1109 1118 2-s2.0-77950621871 10.1016/j.yexcr.2010.02.022
23. Burke J. P., Watson R. W. G., Mulsow J. J., Docherty N. G., Coffey J. C., O'Connell P. R., Endoglin negatively regulates transforming growth factor β 1-induced profibrotic responses in intestinal fibroblasts. British Journal of Surgery 2010 97 6 892 901 2-s2.0-77952777431 10.1002/bjs.6996
24. Rubtsov Y. P., Rudensky A. Y., TGF beta signalling in control of T-cell-mediated self-reactivity. Nature Reviews Immunology 2007 7 443 453 (Pubitemid 46834850)
25. Walsh M. F., Ampasala D. R., Hatfield J., Vander Heide R., Suer S., Rishi A. K., Basson M. D., Transforming growth factor- β stimulates intestinal epithelial focal adhesion kinase synthesis via Smad- and p38-dependent mechanisms. American Journal of Pathology 2008 173 2 385 399 2-s2.0-48749107009 10.2353/ajpath.2008.070729
26. Kaspar J. W., Niture S. K., Jaiswal A. K., Nrf2:INrf2 (Keap1) signaling in oxidative stress. Free Radical Biology and Medicine 2009 47 9 1304 1309 2-s2.0-70349843323 10.1016/j.freeradbiomed.2009.07.035
27. Kobayashi M., Yamamoto M., Nrf2-Keap1 regulation of cellular defense mechanisms against electrophiles and reactive oxygen species. Advances in Enzyme Regulation 2006 46 1 113 140 2-s2.0-33748052967 10.1016/j.advenzreg.2006.01.007 (Pubitemid 44301353)
28. Lastres-Becker I., Cartmell T., Molina-Holgado F., Endotoxin preconditioning protects neurones from in vitro ischemia: role of endogenous IL-1 β and TNF- α Journal of Neuroimmunology 2006 173 1-2 108 116 2-s2.0-33644937686 10.1016/j.jneuroim.2005.12.006
29. Loos B., Smith R., Engelbrecht A. M., Ischaemic preconditioning and TNF- α -mediated preconditioning is associated with a differential cPLA2 translocation pattern in early ischaemia. Prostaglandins Leukotrienes and Essential Fatty Acids 2008 78 6 403 413 2-s2.0-46049114843 10.1016/j.plefa.2008. 05.002
30. García-Prieto E., González-López A., Cabrera S., Astudillo A., Gutiérrez-Fernández A., Fanjul-Fernandez M., Batalla-Solís E., Puente X. S., Fueyo A., López-Otín C., Albaiceta G. M., Resistance to bleomycin-induced lung fibrosis in MMP-8 deficient mice is mediated by interleukin-10. PLoS One 2010 5 10 10.1371/journal.pone.0013242 e13242